In 2008, sales of transfusion management products in the countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) totaled approximately $245.5 million; over the forecast period covered by this report, sales of these products are expected to increase at a compound annual rate of 3.8%, reaching an estimated $296.3 million in the year 2013.
This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of transfusion management. Market segments covered by this report include blood salvage equipment and disposables and plasma volume expanders. This report also includes an update on the progress of clinical development of blood substitutes, or intravascular oxygen carriers, as well as an analysis of critical care in Europe and a discussion of the healthcare structures and regulations in France, Germany, Italy, Spain, and the U.K.
EXECTIVE SUMMARY i. Clinical Overview ii. European Markets for Transfusion Management Products a. Blood Salvage/Autotransfusion Systems b. Blood Substitutes/Intravascular Oxygen Carriers c. Plasma Volume Expanders iii. Market Analysis iv. Methodology Exhibit ES-1: Europe, Transfusion Management Products, Combined Market Forecast, 2008-2013 1. EUROPEAN HEALTHCARE MARKETS 1.1 The European Union 1.1.1 A Common Currency 1.1.2 Regulatory Policies 1.1.3 Reimbursement 1.1.4 Healthcare Spending 1.2 Selected European National Healthcare Profiles 1.2.1 France 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement 1.2.2 Germany 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Device Reimbursement 1.2.3 Italy 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement 1.2.4 Spain 184.108.40.206 Healthcare Organization and Reform 220.127.116.11 Hospital Services 18.104.22.168 Medical Device Reimbursement 1.2.5 United Kingdom 22.214.171.124 Healthcare Organization and Reform 126.96.36.199 Hospital Services 188.8.131.52 Medical Device Reimbursement Exhibit 1-1: European Union, Medical Devices Risk Classification System Exhibit 1-2: Europe, Population Statistics Comparison for the Years 2008 and 2018 Exhibit 1-3: France, Selected National Healthcare Statistics Exhibit 1-4: Germany, Selected National Healthcare Statistics Exhibit 1-5: Italy, Selected National Healthcare Statistics Exhibit 1-6: Spain, Selected National Healthcare Statistics Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics 2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT 2.1 Conditions Treated in the Critical Care Unit 2.2 Critical Care Unit Staffing 2.2.1 Intensivists 2.2.2 Nurses and Other Allied Healthcare Professionals 2.3 Critical Care Units, by Size and Type 2.4 Equipment and Products Used in the Critical Care Setting 2.4.1 Invasive and Noninvasive Equipment and Products 2.4.2 Transport Equipment and Products 2.5 Critical Access Hospital Designation 2.6 Issues Affecting Critical Care Delivery 2.6.1 Patient Demographics 2.6.2 Managed Care 2.6.3 Healthcare Personnel Shortages 2.6.4 Trends in Critical Care Product Purchasing Exhibit 2-1: 2006, Number of Anesthetists/Intensivists in Selected European Countries Exhibit 2-2: Selected Critical Care Nursing and Allied Healthcare Responsibilities Exhibit 2-3: 2006, Number of Emergency Rooms and Beds in Selected European Countries Exhibit 2-4: 2006, Total Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European Countries Exhibit 2-5: 2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-6: 2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-7: 2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-8: 2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility Exhibit 2-9: 2006, United Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility 3. EUROPEAN MARKETS FOR TRANSFUSION MANAGEMENT PRODUCTS 3.1 Clinical Overview 3.1.1 Banked Blood Supply 3.1.2 Allogeneic and Autologous Blood Transfusions 3.1.3 Blood Bank Product Safety and Testing Protocols 3.1.4 Blood Components 3.1.5 Incidence of Blood Transfusions 3.2 Blood Salvage/Autotransfusion Systems 3.2.1 Applications 3.2.2 Costs 3.2.3 Risks 3.2.4 Intraoperative and Postoperative Blood Salvage 3.2.5 Market Forecast 3.2.6 Competitive Analysis 3.3 Blood Substitutes/Intravascular Oxygen Carriers 3.4 Plasma Volume Expanders 3.4.1 Colloid Solutions 184.108.40.206 Human Serum Albumin 220.127.116.11 Plasma Protein Fraction 18.104.22.168 Hydroxyethyl Starch 22.214.171.124 Dextran 126.96.36.199 Gelatin 3.4.2 Crystalloid Solutions 188.8.131.52 Normal Saline 184.108.40.206 Dextrose Solutions 220.127.116.11 Hartmann's Solution 3.4.3 Market Forecast 3.4.4 Competitive Analysis 3.5 Combined Market Forecast Exhibit 3-1: 2009, Selected Blood Salvage/Autotransfusion Systems Exhibit 3-2: Europe, Blood Salvage Systems, Combined Market Forecast, 2008-2013 Exhibit 3-3: Europe, Blood Salvage Equipment, Market Forecast, 2008-2013 Exhibit 3-4: Europe, Blood Salvage Disposables, Market Forecast, 2008-2013 Exhibit 3-5: 2008, Blood Salvage Products Market, Share by Supplier Exhibit 3-6: 2009, Types of Plasma Volume Expanders and Their Indications Exhibit 3-7: 2009, Selected Plasma Volume Expanders Exhibit 3-8: Europe, Plasma Volume Expanders, Combined Market Forecast, 2008-2013 Exhibit 3-9: Europe, Colloids, Market Forecast, 2008-2013 Exhibit 3-10: Europe, Crystalloids, Market Forecast, 2008-2013 Exhibit 3-11: Europe, Transfusion Management Products, Combined Market Forecast, 2008-2013 4. COMPANY PROFILES 4.1 Baxter International, Inc. 4.2 B. Braun Melsungen AG 4.3 CSL Behring LLC/CSL LTD 4.4 Fresenius SE 4.5 Grifols SA 4.6 Haemonetics Corporation 4.7 Oxygen Biotherapeutics, Inc. 4.8 Sangart, Inc. 4.9 Sorin SPA 4.10 Talecris Biotherapeutics, Inc. APPENDIX: COMPANY LISTING